Rasi responds to concerns on transparency policy

EMA Director Guido Rasi said on Thursday that EMA's proposed clinical data transparency policy is "by no means intended to limit the exercise of the EU citizens' right to have access to documents." In a (see BioCentury Extra, May 21).

EMA is slated to present the policy to the agency's management board on June 12. The board is scheduled to discuss the final policy and implementation. ...